Beauty Health (NASDAQ:SKIN) Share Price Crosses Above 50 Day Moving Average – What’s Next?

The Beauty Health Company (NASDAQ:SKIN – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $12.30 and traded as high as $15.95. Beauty Health shares last traded at $15.71, with a volume of 433,975 shares traded.

Wall Street Analyst Weigh In

SKIN has been the subject of several recent analyst reports. Canaccord Genuity Group set a $11.00 target price on shares of Beauty Health and gave the stock a “hold” rating in a report on Thursday, October 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beauty Health in a report on Wednesday, October 21st. Zacks Research cut shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Jefferies Financial Group reaffirmed a “hold” rating and set a $11.00 target price (up from $0.85) on shares of Beauty Health in a report on Monday, October 19th. Finally, Citigroup restated a “hold” rating on shares of Beauty Health in a research report on Thursday, October 15th. One analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Beauty Health currently has a consensus rating of “Hold” and a consensus price target of $18.00.

Read Our Latest Analysis on Beauty Health

Beauty Health Stock Up 51.8%

The firm has a market capitalization of $102.27 million, a price-to-earnings ratio of -5.73 and a beta of 1.05. The firm has a 50 day moving average of $12.30 and a two-hundred day moving average of $16.38. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36.

Beauty Health (NASDAQ:SKIN – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.33) by $1.19. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The company had revenue of $69.17 million for the quarter, compared to analyst estimates of $67.97 million. As a group, sell-side analysts anticipate that The Beauty Health Company will post -3.18 EPS for the current fiscal year.

Hedge Funds Weigh In On Beauty Health

An institutional investor recently raised its position in Beauty Health stock. Renaissance Technologies LLC increased its position in The Beauty Health Company (NASDAQ:SKIN – Free Report) by 29.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 283,791 shares of the company’s stock after acquiring an additional 64,900 shares during the period. Renaissance Technologies LLC owned approximately 0.22% of Beauty Health worth $253,000 as of its most recent SEC filing. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Company Profile

(Get Free Report)

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.

Read More

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.